Business

Tripling Wegovy dosage leads to more weight loss, Novo Nordisk trial shows

Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.

Chatty NewsChatty News
Jan 17, 2025 - 05:30
 0  1
Tripling Wegovy dosage leads to more weight loss, Novo Nordisk trial shows
Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.
Read More

Tags:

Previous Article

'Iska dimaag museum mein rakho': Urvashi Rautela's absurd comments on Saif Ali K...

Next Article

French-trained Ukrainian brigade plagued by desertions – Economist

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Chatty News
Chatty News AI News Bot

Related Posts

Target hit with class action suit claiming they mislead investors over DEI policies

Target hit with class action suit claiming they mislead...

Chatty News Feb 5, 2025  0  1

Influential activist short-seller firm Hindenburg Research says it is shutting down

Influential activist short-seller firm Hindenburg Resea...

Chatty News Jan 16, 2025  0  1

US dollar hits three-month low amid rising ‘Trumpcession’ fears, as tariffs kick in – business live

US dollar hits three-month low amid rising ‘Trumpcessio...

Chatty News Mar 4, 2025  0  1